Snakebite envenoming in Kerala, South India: Clinical profile and factors involved in adverse outcomes

Emergency Medicine Journal

Volumn 25, Issue 4, 2008, Pages 200-204

  Suchithra, N ^a   Pappachan, J M ^a   Sujathan, P ^a  

^a Kottayam Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SNAKE VENOM ANTISERUM; TETANUS TOXOID;

ACUTE KIDNEY FAILURE; ADULT; ADVERSE OUTCOME; ANAPHYLAXIS; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CAPILLARY LEAK SYNDROME; DIAPHRAGM PARALYSIS; DRUG HYPERSENSITIVITY; EMERGENCY; EMERGENCY CARE; ENVENOMATION; FEMALE; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INDIA; LEUKOCYTOSIS; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SNAKEBITE;

ADULT; ANTIVENINS; BLOOD COAGULATION DISORDERS; DRUG ADMINISTRATION SCHEDULE; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INDIA; KIDNEY FAILURE, ACUTE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SNAKE BITES; SNAKE VENOMS; TREATMENT OUTCOME;

EID: 41849104170     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.051136     Document Type: Article

References (28)

1. Chippaux JP. Snakebites: appraisal of the global situation. Bull WHO 1998;76:515-24.
2. Agarwal R, Aggarwal AN, Gupta D, et al. Low dose of snake antivenom is as effective as high dose in patients with severe neurotoxic snake envenoming. Emerg Med J 2005;22:397-9.
3. Cheng AC, Currie BJ. Venomous snakebites worldwide with a focus on the Australia-Pacific region: current management and controversies. J Intensive Care Med 2004;19:259-69.
4. Bambery P. Snake bites and arthropod envenomation. In: Shah SN, ed. API textbook of medicine. 7th edn. Mumbai: The Association of Physicians of India. 2003:1279-81.
5. Narvencar K. Correlation between timing of ASV administration and complications in snake bites. J Assoc Physicians India 2006; 54:717-9.
6. Punde DP. Management of snakebite in rural Maharashtra: a 10-year experience. Natl Med J India 2005;18:71-5.
7. Gold BS, Wingert WA, Snake venom poisoning in the US: a review of therapeutic practice. South Med J 1994;87:579-89.
8. Auerbach PS, Norris RL. Disorders caused by reptile bites and marine animal exposures. In: Kasper DL, Brownwald E, Fauci AS, et al, ads. Harrison's principles of internal medicine. 16th edn. New Delhi: McGraw Hill, 2004:2593-600.
9. Dart RC, Hurlbut KM, Garcia R, et al. Validation of a severity score for the assessment of crotalid snakebites. Ann Emerg Med 1996;27:321-6.
10. Warrell DA. Treatment of bites by adders and exotic venomous snakes. BMJ 2005;331:1244-7.
11. Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med 2001;37:181-8.
12. Kalantri S, Singh A, Joshi R, et al. Clinical predictors of in-hospital mortality in patients with snakebite: a retrospective study from a rural hospital in central India. Trop Med Int Health 2006;11:22-30.
13. Pinho FM, Zanetta DM, Burdmann EA. Acute renal failure after Crotalus durissus snakebite: a prospective survey on 100 patients. Kidney Int 2005;67:659-67.
14. Schneemann M, Cathomas H, Laidlaw ST, et al. Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review. Q J Med 2004; 97:717-27.
15. Sharma SK, Chappuis F, Jha N, et al. Impact of snake bites and determinants of fatal outcomes in southeastern Nepal. Am J Trop Med Hyg 2004;71:234-8.
16. Bawaskar HS, Bawaskar PH. Profile of snakebite envenoming in western Maharashtra, India. Trans R Soc Trop Med Hyg 2002; 96:79-84.
17. Kutty VR. Historical analysis of the development of healthcare facilities in Kerala State, India. Health Policy Plan 2000; 15:103-9.
18. UNDP. Human Development Report 2006. http://hdr.undp.org/hdr2006/ statistics/countries/data_sheets/cty_ds_India.html (accessed 16 Nov 2007).
19. Kularatne SA. Common krait (Bungarus caeruleus) bite in Anuradhapura, Sri Lanka: a prospective clinical study, 1996-98. Postgrad Med J 2002;78:276-80.
20. Sharma N, Chauhan S, Faruqi S, et al. Snake envenomation in a north Indian hospital. Emerg Med J 2005;22:118-20.
21. Kularatne SA. Epidemiology and clinical picture of the Russell's viper (Daboia russelii russelii) bite in Anuradhapura, Sri Lanka: a prospective study of 336 patients. Southeast Asian J Trop Med Public Health 2003;34:855-62.
22. Seneviratne U, Dissanayake S. Neurological manifestations of snake bite in Sri Lanka. J Postgrad Med 2002;48:275-8.
23. McGain F, Limbo A, Williams DJ, et al. Snakebite mortality at Port Moresby General Hospital, Papua New Guinea, 1992-2001. Med J Aust 2004;181:687-91.
24. Mosquera A, Idrovo LA, Tafur A, et al. Stroke following Bothrops spp snakebite. Neurology 2003;60:1577-80.
25. Clark RF, McKinney PE, Chase PB, et al. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med 2002;39:671-6.
26. Jayakumar M, Prabahar MR, Fernando EM, et al. Epidemiologic trend changes in acute renal failure: a tertiary center experience from South India. Ren Fail 2006;28:405-10.
27. Isbister GK, Williams V, Brown SG, White J, Currie BJ, Australian Snakebite Project Investigators. Clinically applicable laboratory end-points for treating snakebite coagulopathy. Pathology 2006; 38:568-72.
28. Bebarta V, Dart RC. Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom. J Toxicol Clin Toxicol 2004;42:321-4.